Impaired neutralisation of SARS-CoV-2 delta variant in vaccinated patients with B cell chronic lymphocytic leukaemia
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Impaired neutralisation of SARS-CoV-2 delta variant in vaccinated patients with B cell chronic lymphocytic leukaemia
Authors
Keywords
-
Journal
Journal of Hematology & Oncology
Volume 15, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-01-10
DOI
10.1186/s13045-021-01219-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy of the BNT162b2 mRNA COVID-19 Vaccine in Patients with Chronic Lymphocytic Leukemia
- (2021) Yair Herishanu et al. BLOOD
- Heterologous prime-boost COVID-19 vaccination: initial reactogenicity data
- (2021) Robert H Shaw et al. LANCET
- Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19
- (2021) Nicole Doria-Rose et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antibody response to SARS-CoV-2 vaccines in patients with hematologic malignancies
- (2021) Lee M. Greenberger et al. CANCER CELL
- Validation of a combined ELISA to detect IgG, IgA and IgM antibody responses to SARS-CoV-2 in mild or moderate non-hospitalised patients
- (2021) A.M. Cook et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant
- (2021) Jamie Lopez Bernal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel
- (2021) Yinon M. Bar-On et al. NEW ENGLAND JOURNAL OF MEDICINE
- Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants
- (2021) Venkata-Viswanadh Edara et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antibody responses after first and second Covid-19 vaccination in patients with chronic lymphocytic leukaemia
- (2021) H. Parry et al. Blood Cancer Journal
- Antibody responses to SARS-CoV-2 vaccines in 45,965 adults from the general population of the United Kingdom
- (2021) Jia Wei et al. Nature Microbiology
- COVID-19 in vaccinated adult patients with hematological malignancies. Preliminary results from EPICOVIDEHA
- (2021) Livio Pagano et al. BLOOD
- COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA)
- (2021) Livio Pagano et al. Journal of Hematology & Oncology
- Outcomes of COVID-19 in Patients with CLL: A Multicenter, International Experience
- (2020) Anthony R. Mato et al. BLOOD
- COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus
- (2020) Lydia Scarfò et al. LEUKEMIA
- Vaccines for SARS-CoV-2: Lessons from Other Coronavirus Strains
- (2020) Eriko Padron-Regalado Infectious Diseases and Therapy
- Anti-SARS-CoV-2 antibody response in patients with chronic lymphocytic leukemia
- (2020) Lindsey E. Roeker et al. LEUKEMIA
- Effect of Bruton tyrosine kinase inhibitor on efficacy of adjuvanted recombinant hepatitis B and zoster vaccines
- (2020) Christopher Pleyer et al. BLOOD
- Guideline for the treatment of chronic lymphocytic leukaemia
- (2018) Anna H. Schuh et al. BRITISH JOURNAL OF HAEMATOLOGY
- Perturbation of the normal immune system in patients with CLL
- (2015) F. Forconi et al. BLOOD
- Poor functional antibody responses are present in nearly all patients with chronic lymphocytic leukaemia, irrespective of total IgG concentration, and are associated with increased risk of infection
- (2015) Helen M. Parry et al. BRITISH JOURNAL OF HAEMATOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started